News
- Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
- WHO establishes Council on the Economics of Health for All
- The clinical study of NO-mediated Vascular Function in Covid-19 Patient begins in Italy
- Cancer research institute launches a master protocol empowering mechanobiology translation research in Breast Cancer
- University hospital evaluates сoagulopathy and мasculopathy as a predictor of the severity of SARS-CoV-2 / COVID-19 infection
- Pharmaceutical company assesses skin irritation and sensitization for HP-1050 patch
- Research Hospital started a new clinical trial of Immune Response evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer patients treated with SBRT
- Glaukos Corporation evaluates the rate of clinically relevant complications associated with iStent inject
- Neglected tropical diseases: World Health Assembly endorses bold new road map targets for 2030
- UNICEF and PAHO launch joint COVID-19 vaccine tender on behalf of COVAX Facility
- WHO HTS Info app
- Hydroxychloroquine does not benefit adults hospitalized with COVID-19
- Nearly 1 in 5 COVID-19 deaths in the African region linked to diabetes
- Updated dashboard supports differentiated HIV testing services
- PAHO outlines best practices to control COVID-19 pandemic
- Cross-disciplinary team will design, develop devices to better treat spinal cord injuries
- Czech National Institute of Mental Health consider virtual tasks vs paper-pencil methods in cognitive rehabilitation in patients with Schizophrenia and Depression
- University of Leipzig conducts Analysis of Mental Disorders, Psychosocial Distress and Psycho-oncological Care Needs of Patients and Their Relatives
- University of Washington conducts clinical trial of Glargine to Degludec Insulin Transition
- The effect of low-volume training and resistance exercise in individual with Stroke
- Private research university is using Smart Watches to detect and monitor COVID-19
- Pharmaceutical enterprise evaluates the efficacy of Nafabelltan in hospitalized patients diagnosed with COVID-19 pneumonia
- Pharmaceutical company started a new clinical trial of Masitinib combined with Isoquercetin in hospitalized patients with COVID-19
- Italian company conducts clinical trial of plasmApuane CoV-2
- Biotechnology company started first-in-human study of IMGC936 in patients with advanced Solid Tumors
Clinical Research News
今後の臨床試験
-
Aperta Biosciences, LLCまだ募集していません
-
Hospices Civils de Lyonまだ募集していません尿失禁 | 神経因性膀胱 | 尿路変更 | 骨盤悪性腫瘍 | 膀胱がんフランス
-
Second Affiliated Hospital, Zhejiang University...募集正常な聴力 | 騒音暴露 | Preferred Loudness Level中国
-
Qilu Pharmaceutical Co., Ltd.まだ募集していません明細胞腎細胞がん | 卵巣がん | その他の進行性固形腫瘍中国
-
University Hospital, Antwerpまだ募集していません
-
VA Office of Research and Developmentまだ募集していません転移性非小細胞肺がん | Cancer-Associated Weight Loss | Elevated Inflammatory Markersアメリカ
-
ENTire Medical Ltd.まだ募集していません肥大 | 扁桃摘出術 | 気道閉塞アッパー | アデノイド切除手術アメリカ
-
AbbVieまだ募集していません
-
Institute of Hematology & Blood Diseases Hospital...募集
-
Ahmed Nasser Ali Mabkhout募集顎嚢胞 | Alveolar Bone Defectsイエメン
-
University of Coimbraまだ募集していません
